Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Storti, Sergio
FIL_PREVID, NCT04442412 / 2019-004474-26: Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy	Recruiting	3	430	Europe	Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses	Fondazione Italiana Linfomi ONLUS, GRADE Onlus	Diffuse Large B-Cell Lymphoma, Elderly Patients	09/25	09/30
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis	Recruiting	N/A	400	Europe	Treatment for clinical practise	Fondazione Italiana Linfomi ONLUS	Classical Hodgkin Lymphoma	01/26	01/26
Fraticelli, Vincenzo
ARISE, NCT06205498: Acalabrutinib Real World Italian obSErvational Study -	Recruiting	N/A	190	Europe	acalabrutinib, Calquence	AstraZeneca, Yghea	Chronic Lymphocytic Leukemia	02/30	02/30

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Storti, Sergio
FIL_PREVID, NCT04442412 / 2019-004474-26: Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy	Recruiting	3	430	Europe	Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses	Fondazione Italiana Linfomi ONLUS, GRADE Onlus	Diffuse Large B-Cell Lymphoma, Elderly Patients	09/25	09/30
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis	Recruiting	N/A	400	Europe	Treatment for clinical practise	Fondazione Italiana Linfomi ONLUS	Classical Hodgkin Lymphoma	01/26	01/26
Fraticelli, Vincenzo
ARISE, NCT06205498: Acalabrutinib Real World Italian obSErvational Study -	Recruiting	N/A	190	Europe	acalabrutinib, Calquence	AstraZeneca, Yghea	Chronic Lymphocytic Leukemia	02/30	02/30